Accelerating Oncology Trial Recruitment by Identifying Patients at Diagnosis


In the following Clinical Researcher article, Worldwide’s Meghann Howland, Vice President for Therapeutic Area Strategy in Oncology/Hematology, and Dr. T.J. Bowen, Chief Scientific Officer and Co-Founder of Deep Lens, discuss the new opportunities and benefits of identifying patients at diagnosis, in order to improve your oncology trial recruitment.

Questions regarding your upcoming oncology clinical trial?